DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

310.27 4.25 (1.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $310.27 1.39%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $311.39
Previous Close $306.02
Daily Range $307.22 - $314.05
52-Week Range $227.64 - $352.49
Market Cap $31.3B
P/E Ratio 87.68
Dividend (Yield) $0.00 (0.0%)
Volume 522,936
Average Daily Volume 969,840
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog

3 Stocks Reiterated As A Hold: NTAP, FSLR, REGN

InsiderInsights.com Daily Round Up: 7/17/14

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Sector Update: Health Care Shares Mixed Pre-Market

Sector Update: Health Care

Notable Two Hundred Day Moving Average Cross - REGN

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

SHPG, REGN And LLY, 3 Drugs Stocks Pushing The Industry Lower

Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron

See More REGN News...

REGN's Top Competitors

REGN $310.27 (1.39%)
Current stock: REGN
AMGN $122.01 (0.74%)
Current stock: AMGN
GILD $90.34 (1.13%)
Current stock: GILD
BIIB $337.60 (11.17%)
Current stock: BIIB